| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Donna Shiroma last filed a Form 4 in May 2024, as General Counsel at RCEL. Donna Shiroma's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 45,951 shares of RCEL. The RCEL filings lean toward selling, a net 4,193 shares.
Donna Shiroma has 7 Form 4 filings on record from September 2020 to May 2024, all as General Counsel at AVITA Medical (RCEL), 2020–2024.
The 11 reported transactions were 6 option or other derivative awards, 4 stock awards and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $66K.
The only open-market sale was 4,193 shares of RCEL at an average $15.84 on August 21, 2023, about $66K. Twelve months later RCEL was down 45%.
Shares as reported in the last Form 4 for each company; the most recent is from May 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2023 | RCEL Avita Medical, Inc. | General Counsel | Sell | 4,193 | $15.84 | $66,417.12 | -9.0% | -22.5% | -45.2% |